post-stroke

Showing 1 posts of 1 posts found.

Acorda forced to stop development of drug

November 21, 2016
Manufacturing and Production, Research and Development Acorda therapeutics, clinical trial, post-stroke

Acorda Therapeutics announced that they were unable to continue development of the drug, dalfampridine, due to lack of efficacy in …

The Gateway to Local Adoption Series

Latest content